Bank of New York Mellon’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.58M | Buy |
271,435
+9,197
| +4% | +$291K | ﹤0.01% | 1976 |
|
|
2025
Q1 | $8.7M | Sell |
262,238
-3,401
| -1% | -$113K | ﹤0.01% | 1914 |
|
|
2024
Q4 | $9.14M | Buy |
265,639
+32,272
| +14% | +$1.11M | ﹤0.01% | 1962 |
|
|
2024
Q3 | $9.33M | Sell |
233,367
-36,460
| -14% | -$1.46M | ﹤0.01% | 1974 |
|
|
2024
Q2 | $8.14M | Sell |
269,827
-18,820
| -7% | -$568K | ﹤0.01% | 2072 |
|
|
2024
Q1 | $9.69M | Sell |
288,647
-14,842
| -5% | -$498K | ﹤0.01% | 1971 |
|
|
2023
Q4 | $9.8M | Buy |
303,489
+39,094
| +15% | +$1.26M | ﹤0.01% | 2000 |
|
|
2023
Q3 | $8.66M | Buy |
264,395
+10,538
| +4% | +$345K | ﹤0.01% | 2028 |
|
|
2023
Q2 | $8.93M | Sell |
253,857
-6,713
| -3% | -$236K | ﹤0.01% | 2000 |
|
|
2023
Q1 | $8.51M | Sell |
260,570
-13,067
| -5% | -$427K | ﹤0.01% | 2008 |
|
|
2022
Q4 | $15.1M | Buy |
273,637
+4,235
| +2% | +$233K | ﹤0.01% | 1705 |
|
|
2022
Q3 | $11.9M | Buy |
269,402
+42,280
| +19% | +$1.87M | ﹤0.01% | 1803 |
|
|
2022
Q2 | $11.1M | Buy |
227,122
+9,818
| +5% | +$479K | ﹤0.01% | 1872 |
|
|
2022
Q1 | $10.6M | Buy |
217,304
+17,893
| +9% | +$871K | ﹤0.01% | 2041 |
|
|
2021
Q4 | $8.5M | Buy |
199,411
+130,858
| +191% | +$5.58M | ﹤0.01% | 2186 |
|
|
2021
Q3 | $2.63M | Buy |
68,553
+23,407
| +52% | +$897K | ﹤0.01% | 2835 |
|
|
2021
Q2 | $1.28M | Buy |
45,146
+32,069
| +245% | +$906K | ﹤0.01% | 3264 |
|
|
2021
Q1 | $432K | Buy |
13,077
+1,779
| +16% | +$58.8K | ﹤0.01% | 3759 |
|
|
2020
Q4 | $408K | Buy |
+11,298
| New | +$408K | ﹤0.01% | 3712 |
|